ac

Accendra Health

ACH
NYSE
$2.93

Accendra Health a-t-elle une direction de haute qualité ?

CEO Edward Pesicka and team have steered a complex carve-out and are addressing the capital structure proactively. Governance looks conventional and large long-term holders such as Coliseum are engaged, which can support discipline.

Execution risk remains around payer transitions and operational service, as public consumer sentiment on Apria is mixed and will require sustained process improvement.